US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Sagimet Biosciences Inc.

2.55

+0.16006.69%

Post-market: 2.550.00000.00%16:37 EDT

Volume:903.16K

Turnover:2.26M

Market Cap:82.10M

PE:-1.75

High:2.60

Open:2.45

Low:2.36

Close:2.39

Loading ...

Overview Company News Filings

Press Release: Sagimet Biosciences Reports Third Quarter 2024 Financial Results and Provides Corporate Updates

Sagimet Biosciences Inc : UBS Initiates Coverage With Buy Rating and Target Price $12

THOMSON REUTERS

UBS Initiates Sagimet Biosciences at Buy With $12 Price Target

MT Newswires Live

Calendar of U.S. Earnings Expected in the Week Ahead

Calendar of U.S. Earnings Expected in the Week Ahead

Sagimet Biosciences to Participate in the UBS Global Healthcare Conference

Sagimet Biosciences Price Target Maintained With a $32.00/Share by HC Wainwright & Co.

Sagimet Biosciences’ Denifanstat: Promising Phase 3 Prospects and Strong Buy Recommendation

BRIEF-Sagimet Biosciences Announces Successful Completion Of End-Of-Phase 2 Interactions With FDA On The Development Of Denifanstat For Mash Phase 3 Program Initiation Expected By End Of 2024

Sagimet Biosciences completes End-of-Phase 2 meeting with FDA on denifanstat

Sagimet Biosciences Announces Successful Completion of End-of-Phase 2 Interactions With FDA on the Development of Denifanstat for Mash; Phase 3 Program Initiation Expected by End of 2024

THOMSON REUTERS

Sagimet Biosciences Announces Successful Completion of End-of-Phase 2 Interactions with FDA on the Development of Denifanstat for MASH; Phase 3 Program Initiation Expected by End of 2024

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/SGMT/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"SGMT","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SGMT\",,,,,undefined,":{"symbol":"SGMT","market":"US","secType":"STK","nameCN":"Sagimet Biosciences Inc.","latestPrice":2.55,"timestamp":1745352000000,"preClose":2.39,"halted":0,"volume":903155,"hourTrading":{"tag":"盘后","latestPrice":2.55,"preClose":2.55,"latestTime":"16:37 EDT","volume":372,"amount":948.5999999999999,"timestamp":1745354276578},"delay":0,"floatShares":20491361,"shares":32195345,"eps":-1.453459,"marketStatus":"Post-Mkt","change":0.16,"latestTime":"04-22 17:13:46 EDT","open":2.45,"high":2.6,"low":2.355,"amount":2259158.780978,"amplitude":0.10251,"askPrice":2.65,"askSize":60,"bidPrice":2.37,"bidSize":30,"shortable":3,"etf":0,"ttmEps":-1.453459,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1745366400000},"marketStatusCode":4,"adr":0,"listingDate":1689307200000,"exchange":"NASDAQ","adjPreClose":2.39,"preHourTrading":{"tag":"盘前","latestPrice":2.43,"preClose":2.39,"latestTime":"09:28 EDT","volume":6771,"amount":16635.8114139,"timestamp":1745328480035},"postHourTrading":{"tag":"盘后","latestPrice":2.55,"preClose":2.55,"latestTime":"16:37 EDT","volume":372,"amount":948.5999999999999,"timestamp":1745354276578},"volumeRatio":1.456831,"impliedVol":0.9606,"impliedVolPercentile":0.0354},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SGMT\",,,,,undefined,":{"symbol":"SGMT","floatShares":20491361,"roa":"-26.49%","roe":"-36.92%","lyrEps":-1.453459,"volumeRatio":1.456831,"shares":32195345,"dividePrice":0,"high":2.6,"amplitude":0.10251,"preClose":2.39,"low":2.355,"week52Low":1.73,"pbRate":"0.53","week52High":7.38,"institutionHeld":0,"latestPrice":2.55,"committee":-0.333333,"eps":-1.453459,"divideRate":0,"volume":903155,"delay":0,"ttmEps":-1.453459,"open":2.45,"prevYearClose":4.5,"prevWeekClose":2.21,"prevMonthClose":3.26,"prevQuarterClose":3.26,"fiveDayClose":2.38,"twentyDayClose":4.13,"sixtyDayClose":4.2},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"SGMT\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2483877540","title":"Press Release: Sagimet Biosciences Reports Third Quarter 2024 Financial Results and Provides Corporate Updates","url":"https://stock-news.laohu8.com/highlight/detail?id=2483877540","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483877540?lang=en_us&edition=fundamental","pubTime":"2024-11-14 21:00","pubTimestamp":1731589200,"startTime":"0","endTime":"0","summary":"Denifanstat received Breakthrough Therapy designation from FDA for MASH. Successful completion of end-of-Phase 2 interactions with FDA on the development of denifanstat for MASH; Phase 3 program initiation expected by end of 2024. Anticipated cash runway through 2025, with cash, cash equivalents and marketable securities totaling $170.0 million as of September 30, 2024. \"As we approach the end of 2024, the Sagimet team remains focused on advancing denifanstat towards a pivotal Phase 3 program in MASH,\" said David Happel, Chief Executive Officer of Sagimet. \"The publication of our Phase 2b FASCINATE-2 study results in a highly regarded Lancet journal highlighted denifanstat's strong efficacy and tolerability data and its highly differentiated mechanism of action which enables denifanstat to improve the key drivers of MASH: fat accumulation, inflammation, and fibrosis. In addition, we are proud to have recently received Breakthrough Therapy designation for denifanstat in MASH from the FD","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SGMT","BK4139"],"gpt_icon":0},{"id":"2482084528","title":"Sagimet Biosciences Inc : UBS Initiates Coverage With Buy Rating and Target Price  $12","url":"https://stock-news.laohu8.com/highlight/detail?id=2482084528","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2482084528?lang=en_us&edition=fundamental","pubTime":"2024-11-12 23:25","pubTimestamp":1731425109,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241112:nAZN2LPJ6U:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","SGMT"],"gpt_icon":0},{"id":"2482034937","title":"UBS Initiates Sagimet Biosciences at Buy With $12 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2482034937","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2482034937?lang=en_us&edition=fundamental","pubTime":"2024-11-12 20:17","pubTimestamp":1731413825,"startTime":"0","endTime":"0","summary":"Sagimet Biosciences (SGMT) has an average outperform rating and a price target range of $6 to $67, according to analysts polled by Capital IQ.(MT Newswires covers equity, commodity and economic resear","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["SGMT"],"gpt_icon":0},{"id":"2482420129","title":"Calendar of U.S. Earnings Expected in the Week Ahead","url":"https://stock-news.laohu8.com/highlight/detail?id=2482420129","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2482420129?lang=en_us&edition=fundamental","pubTime":"2024-11-11 19:00","pubTimestamp":1731322800,"startTime":"0","endTime":"0","summary":"Major companies tentatively scheduled to report quarterly earnings in the week ahead, with earnings estimates provided by FactSet Research Systems Inc.·Angi Inc Class A                                3Q       .00       AMC. ·Global Ship Lease                                3Q      2.41   8:00 AM","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ICL","DHT","NOTE","DAVE","IAC","CAE","EQ","NRGV","ABOS","SGMT","DDI","GENI","EARN","FTCI","INTS","DAVA","TSVT","OBIO","FIHL","KEP","ASRT","CHGG","ABSI","FBRX","AXSM","XP","XGN","ATAI","CNTA","DHX","GAUZ","LAZR","AZN","RVPH","FLNG","MLYS","CCLD","TWKS","CRDL","IKT","CYTH","ARMK","ATER","CNNE","BLFS","AVTE","CRVO","GATO","AMTX","CLRB"],"gpt_icon":0},{"id":"2481220901","title":"Calendar of U.S. Earnings Expected in the Week Ahead","url":"https://stock-news.laohu8.com/highlight/detail?id=2481220901","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481220901?lang=en_us&edition=fundamental","pubTime":"2024-11-08 19:00","pubTimestamp":1731063600,"startTime":"0","endTime":"0","summary":"Major companies tentatively scheduled to report quarterly earnings in the week ahead, with earnings estimates provided by FactSet Research Systems Inc.Amer. Axle & Mnfg                                3Q      (.05)  8:00 AM","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HLLY","ANIP","GSL","GCMG","BLMN","WMS","OCS","MSGE","ZETA","SBS","ALT","FLR","BNTC","AHR","AVTE","BAX","ZURA","ATAI","SGMT","VINC","LAZR","XAIR","ABOS","ATOS","INTS","PARA","RBA","XERS","AMRX","AMTX","CLMT","GATO","ACLX","GTN","MASS","HUMA","VRDN","APGE","AGO","COCP","ATSG","AIRS","KT","NRXP","TSVT","FBRX","PAA","NPWR","TSBX","PAGP"],"gpt_icon":1},{"id":"2481909113","title":"Sagimet Biosciences to Participate in the UBS Global Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2481909113","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481909113?lang=en_us&edition=fundamental","pubTime":"2024-11-07 20:30","pubTimestamp":1730982600,"startTime":"0","endTime":"0","summary":"SAN MATEO, Calif., Nov.  07, 2024  (GLOBE NEWSWIRE) -- Sagimet Biosciences Inc.(Sagimet, Nasdaq: SGMT), a clinical-stage biopharmaceutical company developing novel therapeutics targeting dysfunctional","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/11/07/2976572/0/en/Sagimet-Biosciences-to-Participate-in-the-UBS-Global-Healthcare-Conference.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SGMT","BK4139","HCSG","BK4137"],"gpt_icon":0},{"id":"2479770845","title":"Sagimet Biosciences Price Target Maintained With a $32.00/Share by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2479770845","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2479770845?lang=en_us&edition=fundamental","pubTime":"2024-10-31 17:49","pubTimestamp":1730368140,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/SGMT/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  October 31, 2024 05:49 ET (09:49 GMT)","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SGMT"],"gpt_icon":0},{"id":"2479736813","title":"Sagimet Biosciences’ Denifanstat: Promising Phase 3 Prospects and Strong Buy Recommendation","url":"https://stock-news.laohu8.com/highlight/detail?id=2479736813","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2479736813?lang=en_us&edition=fundamental","pubTime":"2024-10-31 00:05","pubTimestamp":1730304316,"startTime":"0","endTime":"0","summary":"Analyst Ed Arce from H.C. Wainwright maintained a Buy rating on Sagimet Biosciences, Inc. Class A (SGMT – Research Report) and keeping the price ta...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/sagimet-biosciences-denifanstat-promising-phase-3-prospects-and-strong-buy-recommendation?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/sagimet-biosciences-denifanstat-promising-phase-3-prospects-and-strong-buy-recommendation?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","SGMT"],"gpt_icon":0},{"id":"2479700864","title":"BRIEF-Sagimet Biosciences Announces Successful Completion Of End-Of-Phase 2 Interactions With FDA On The Development Of Denifanstat For Mash Phase 3 Program Initiation Expected By End Of 2024","url":"https://stock-news.laohu8.com/highlight/detail?id=2479700864","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2479700864?lang=en_us&edition=fundamental","pubTime":"2024-10-29 19:16","pubTimestamp":1730200602,"startTime":"0","endTime":"0","summary":"Oct 29  - Sagimet Biosciences Inc   :   * SAGIMET BIOSCIENCES ANNOUNCES SUCCESSFUL COMPLETION OF END-OF-PHASE 2 INTERACTIONS WITH FDA ON THE DEVELOPMENT OF DENIFANSTAT FOR MASH; PHASE 3 PROGRAM INITIATION EXPECTED BY END OF 2024Source text:    Further company coverage:    ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","SGMT"],"gpt_icon":0},{"id":"2479547090","title":"Sagimet Biosciences completes End-of-Phase 2 meeting with FDA on denifanstat","url":"https://stock-news.laohu8.com/highlight/detail?id=2479547090","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2479547090?lang=en_us&edition=fundamental","pubTime":"2024-10-29 19:05","pubTimestamp":1730199912,"startTime":"0","endTime":"0","summary":"Sagimet Biosciences (SGMT) announced the completion of end-of-Phase 2 interactions with the U.S. Food and Drug Administration, supporting the advan...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/sagimet-biosciences-completes-end-of-phase-2-meeting-with-fda-on-denifanstat?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/sagimet-biosciences-completes-end-of-phase-2-meeting-with-fda-on-denifanstat?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","SGMT"],"gpt_icon":0},{"id":"2479477394","title":"Sagimet Biosciences Announces Successful Completion of End-of-Phase 2 Interactions With FDA on the Development of Denifanstat for Mash; Phase 3 Program Initiation Expected by End of 2024","url":"https://stock-news.laohu8.com/highlight/detail?id=2479477394","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2479477394?lang=en_us&edition=fundamental","pubTime":"2024-10-29 19:00","pubTimestamp":1730199600,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241029:nTUA4HBB0K:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","SGMT"],"gpt_icon":0},{"id":"2479477179","title":"Sagimet Biosciences Announces Successful Completion of End-of-Phase 2 Interactions with FDA on the Development of Denifanstat for MASH; Phase 3 Program Initiation Expected by End of 2024","url":"https://stock-news.laohu8.com/highlight/detail?id=2479477179","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2479477179?lang=en_us&edition=fundamental","pubTime":"2024-10-29 19:00","pubTimestamp":1730199600,"startTime":"0","endTime":"0","summary":"The planned registration program consists of two double-blind, placebo-controlled multicenter Phase 3 trials, FASCINATE-3 and FASCINIT, to evaluate the safety and efficacy of denifanstat in patients w","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/10/29/2970662/0/en/Sagimet-Biosciences-Announces-Successful-Completion-of-End-of-Phase-2-Interactions-with-FDA-on-the-Development-of-Denifanstat-for-MASH-Phase-3-Program-Initiation-Expected-by-End-of.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","SGMT"],"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":3,"totalSize":52,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/SGMT\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"SGMT\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"SGMT\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.2222,"buy":0.6667,"hold":0.1111,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6667,"analysts":9,"updateTime":1738209600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/SGMT\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"SGMT","date":"2025-04-21","current":-1.561475,"percent":0.988067,"low":-15.666506,"twenty":-7.19719,"median":-4.630925,"eighty":-3.287831,"high":-1.342444,"avg":-5.466457,"sd":2.8204,"marketCap":71151712},"quantilePoints":[{"date":"2023-07-21","current":-12.287206,"twenty":-13.337015,"median":-12.553129,"eighty":-11.625533,"marketCap":348354576},{"date":"2023-07-28","current":-12.208993,"twenty":-12.714826,"median":-12.49838,"eighty":-12.113574,"marketCap":346137170},{"date":"2023-08-04","current":-12.733018,"twenty":-12.595364,"median":-12.529665,"eighty":-12.271563,"marketCap":360993794},{"date":"2023-08-11","current":-12.514023,"twenty":-12.565643,"median":-12.517933,"eighty":-12.42486,"marketCap":354785056},{"date":"2023-08-18","current":-9.925184,"twenty":-12.565643,"median":-12.514023,"eighty":-12.265307,"marketCap":281388897},{"date":"2023-08-25","current":-9.359416,"twenty":-12.554693,"median":-12.471006,"eighty":-10.020915,"marketCap":262381858},{"date":"2023-09-01","current":-9.85717,"twenty":-12.553129,"median":-12.459274,"eighty":-9.809842,"marketCap":276335907},{"date":"2023-09-08","current":-10.126447,"twenty":-12.543743,"median":-12.279385,"eighty":-9.775571,"marketCap":283884818},{"date":"2023-09-15","current":-9.791891,"twenty":-12.532793,"median":-11.532454,"eighty":-9.775571,"marketCap":274505868},{"date":"2023-09-22","current":-8.282308,"twenty":-12.524972,"median":-10.126447,"eighty":-9.674388,"marketCap":232186213},{"date":"2023-09-29","current":-7.392878,"twenty":-12.517151,"median":-9.936056,"eighty":-9.403479,"marketCap":207251930},{"date":"2023-10-06","current":-5.866975,"twenty":-12.514023,"median":-9.90613,"eighty":-8.80291,"marketCap":164474765},{"date":"2023-10-13","current":-4.757227,"twenty":-12.495252,"median":-9.80821,"eighty":-7.764969,"marketCap":133364100},{"date":"2023-10-20","current":-3.729078,"twenty":-12.478045,"median":-9.791891,"eighty":-6.978354,"marketCap":104540984},{"date":"2023-10-27","current":-3.647479,"twenty":-12.474916,"median":-9.751091,"eighty":-6.462648,"marketCap":102253435},{"date":"2023-11-03","current":-3.100765,"twenty":-12.467095,"median":-9.681732,"eighty":-5.866975,"marketCap":86926858},{"date":"2023-11-10","current":-2.284775,"twenty":-12.467095,"median":-9.514454,"eighty":-4.757227,"marketCap":64051369},{"date":"2023-11-17","current":-1.981702,"twenty":-12.459274,"median":-9.396135,"eighty":-4.030995,"marketCap":53347428},{"date":"2023-11-24","current":-3.487116,"twenty":-12.32162,"median":-9.116089,"eighty":-3.455541,"marketCap":93873157},{"date":"2023-12-01","current":-3.248971,"twenty":-12.280949,"median":-8.665823,"eighty":-3.326797,"marketCap":87462307},{"date":"2023-12-08","current":-3.436085,"twenty":-12.223071,"median":-7.870232,"eighty":-3.326797,"marketCap":92499403},{"date":"2023-12-15","current":-4.74588,"twenty":-11.827315,"median":-7.466317,"eighty":-3.305106,"marketCap":127759077},{"date":"2023-12-22","current":-4.79691,"twenty":-11.412789,"median":-6.927763,"eighty":-3.326797,"marketCap":129132830},{"date":"2023-12-29","current":-5.009539,"twenty":-10.856914,"median":-6.462648,"eighty":-3.351567,"marketCap":134856803},{"date":"2024-01-05","current":-4.286601,"twenty":-10.142767,"median":-6.27497,"eighty":-3.385054,"marketCap":115395295},{"date":"2024-01-12","current":-6.055674,"twenty":-10.126447,"median":-6.038333,"eighty":-3.402064,"marketCap":163018751},{"date":"2024-01-19","current":-5.494334,"twenty":-10.061168,"median":-5.928097,"eighty":-3.422477,"marketCap":147907462},{"date":"2024-01-26","current":-11.924235,"twenty":-11.412789,"median":-6.047003,"eighty":-3.434384,"marketCap":321000405},{"date":"2024-02-02","current":-11.8484,"twenty":-11.755197,"median":-6.332089,"eighty":-3.449693,"marketCap":318958920},{"date":"2024-02-09","current":-7.10904,"twenty":-11.755197,"median":-6.72671,"eighty":-3.480312,"marketCap":191375352},{"date":"2024-02-16","current":-10.260714,"twenty":-11.412789,"median":-7.18072,"eighty":-3.487116,"marketCap":276218424},{"date":"2024-02-23","current":-7.973973,"twenty":-11.272575,"median":-7.393401,"eighty":-3.512632,"marketCap":214659353},{"date":"2024-03-01","current":-7.263069,"twenty":-10.976358,"median":-7.495026,"eighty":-3.600344,"marketCap":195521817},{"date":"2024-03-08","current":-7.642218,"twenty":-10.478725,"median":-7.466317,"eighty":-3.696438,"marketCap":205728503},{"date":"2024-03-15","current":-5.118509,"twenty":-10.189946,"median":-7.39314,"eighty":-3.910228,"marketCap":137790253},{"date":"2024-03-22","current":-5.509506,"twenty":-10.132975,"median":-7.18072,"eighty":-4.056781,"marketCap":148315897},{"date":"2024-03-28","current":-6.56,"twenty":-10.093807,"median":-7.132737,"eighty":-4.084178,"marketCap":182866572},{"date":"2024-04-05","current":-6.239442,"twenty":-10.00568,"median":-6.795721,"eighty":-4.174333,"marketCap":173930684},{"date":"2024-04-12","current":-5.976126,"twenty":-9.938231,"median":-6.56,"eighty":-4.313817,"marketCap":166590490},{"date":"2024-04-19","current":-4.545061,"twenty":-9.925184,"median":-6.397368,"eighty":-4.392065,"marketCap":126698131},{"date":"2024-04-26","current":-4.487819,"twenty":-9.917562,"median":-6.217851,"eighty":-4.458405,"marketCap":125102437},{"date":"2024-05-03","current":-5.09459,"twenty":-9.886546,"median":-6.182199,"eighty":-4.468439,"marketCap":142016797},{"date":"2024-05-10","current":-5.231972,"twenty":-9.844114,"median":-6.079163,"eighty":-4.479356,"marketCap":145846463},{"date":"2024-05-17","current":-5.429865,"twenty":-9.811474,"median":-6.018678,"eighty":-4.487871,"marketCap":151590963},{"date":"2024-05-24","current":-5.372708,"twenty":-9.791891,"median":-5.987575,"eighty":-4.491214,"marketCap":149995268},{"date":"2024-05-31","current":-6.172899,"twenty":-9.791891,"median":-5.987575,"eighty":-4.501006,"marketCap":172334989},{"date":"2024-06-07","current":-5.315552,"twenty":-9.783731,"median":-5.976126,"eighty":-4.523122,"marketCap":148399574},{"date":"2024-06-14","current":-5.47559,"twenty":-9.751091,"median":-5.952111,"eighty":-4.533251,"marketCap":152867518},{"date":"2024-06-21","current":-4.446773,"twenty":-9.731508,"median":-5.91688,"eighty":-4.519544,"marketCap":124145020},{"date":"2024-06-28","current":-4.698262,"twenty":-9.718452,"median":-5.91688,"eighty":-4.523122,"marketCap":131166075},{"date":"2024-07-05","current":-3.257919,"twenty":-9.685812,"median":-5.888477,"eighty":-4.48795,"marketCap":90954577},{"date":"2024-07-12","current":-3.738033,"twenty":-9.677652,"median":-5.800519,"eighty":-4.448199,"marketCap":104358410},{"date":"2024-07-15","current":-3.806621,"twenty":-9.67602,"median":-5.796735,"eighty":-4.447058,"marketCap":106273243},{"date":"2024-08-02","current":-3.97809,"twenty":-9.674388,"median":-5.79295,"eighty":-4.391494,"marketCap":111060326},{"date":"2024-08-09","current":-3.109312,"twenty":-9.635837,"median":-5.632964,"eighty":-4.048186,"marketCap":86805772},{"date":"2024-08-16","current":-3.011259,"twenty":-9.556995,"median":-5.529634,"eighty":-3.765468,"marketCap":88082328},{"date":"2024-08-23","current":-3.174914,"twenty":-9.5049,"median":-5.509506,"eighty":-3.626007,"marketCap":92869411},{"date":"2024-08-30","current":-3.36039,"twenty":-9.480538,"median":-5.47559,"eighty":-3.517501,"marketCap":98294771},{"date":"2024-09-06","current":-2.913065,"twenty":-9.458966,"median":-5.429865,"eighty":-3.459899,"marketCap":85210078},{"date":"2024-09-13","current":-3.709522,"twenty":-9.418167,"median":-5.410329,"eighty":-3.440029,"marketCap":108507215},{"date":"2024-09-20","current":-3.578597,"twenty":-9.3382,"median":-5.372708,"eighty":-3.459899,"marketCap":104677549},{"date":"2024-09-27","current":-3.076721,"twenty":-9.217671,"median":-5.306102,"eighty":-3.426198,"marketCap":89997161},{"date":"2024-10-04","current":-4.495067,"twenty":-9.063099,"median":-5.281258,"eighty":-3.402458,"marketCap":131485214},{"date":"2024-10-11","current":-4.516888,"twenty":-9.008144,"median":-5.226248,"eighty":-3.408396,"marketCap":132123492},{"date":"2024-10-18","current":-5.891593,"twenty":-8.972181,"median":-5.273199,"eighty":-3.426198,"marketCap":172334989},{"date":"2024-10-25","current":-6.000697,"twenty":-8.935294,"median":-5.292689,"eighty":-3.429281,"marketCap":175526378},{"date":"2024-10-31","current":-5.826131,"twenty":-8.894301,"median":-5.311818,"eighty":-3.436085,"marketCap":170420156},{"date":"2024-11-08","current":-6.753511,"twenty":-8.791513,"median":-5.372708,"eighty":-3.436763,"marketCap":197546960},{"date":"2024-11-15","current":-5.651565,"twenty":-8.755967,"median":-5.41811,"eighty":-3.453095,"marketCap":165313934},{"date":"2024-11-22","current":-3.861691,"twenty":-8.665823,"median":-5.372708,"eighty":-3.487116,"marketCap":144879052},{"date":"2024-11-29","current":-4.882893,"twenty":-8.557843,"median":-5.315552,"eighty":-3.487116,"marketCap":183191513},{"date":"2024-12-06","current":-3.998995,"twenty":-8.332016,"median":-5.292689,"eighty":-3.504949,"marketCap":150030307},{"date":"2024-12-13","current":-3.896017,"twenty":-8.272608,"median":-5.273199,"eighty":-3.525595,"marketCap":146166866},{"date":"2024-12-20","current":-4.350838,"twenty":-8.042693,"median":-5.190447,"eighty":-3.550034,"marketCap":163230399},{"date":"2024-12-27","current":-4.35942,"twenty":-7.978712,"median":-5.107971,"eighty":-3.56885,"marketCap":163552352},{"date":"2025-01-03","current":-3.853109,"twenty":-7.96022,"median":-5.094591,"eighty":-3.578236,"marketCap":144557099},{"date":"2025-01-10","current":-4.608284,"twenty":-7.932249,"median":-5.088866,"eighty":-3.585335,"marketCap":172889002},{"date":"2025-01-17","current":-3.664315,"twenty":-7.891035,"median":-5.014451,"eighty":-3.578519,"marketCap":137474123},{"date":"2025-01-24","current":-3.561337,"twenty":-7.843641,"median":-5.001034,"eighty":-3.577995,"marketCap":133610681},{"date":"2025-01-31","current":-3.484103,"twenty":-7.800873,"median":-4.931489,"eighty":-3.565628,"marketCap":130713100},{"date":"2025-02-07","current":-4.041903,"twenty":-7.796247,"median":-4.899965,"eighty":-3.577995,"marketCap":151640074},{"date":"2025-02-14","current":-3.775875,"twenty":-7.711114,"median":-4.882893,"eighty":-3.5785,"marketCap":141659518},{"date":"2025-02-21","current":-3.454068,"twenty":-7.655997,"median":-4.848447,"eighty":-3.56477,"marketCap":129586263},{"date":"2025-02-28","current":-3.097934,"twenty":-7.585345,"median":-4.824006,"eighty":-3.534402,"marketCap":116225195},{"date":"2025-03-07","current":-3.13226,"twenty":-7.533213,"median":-4.786117,"eighty":-3.487116,"marketCap":117513009},{"date":"2025-03-14","current":-2.479989,"twenty":-7.4778,"median":-4.774032,"eighty":-3.471231,"marketCap":113005660},{"date":"2025-03-21","current":-2.861526,"twenty":-7.417463,"median":-4.751553,"eighty":-3.434384,"marketCap":130391147},{"date":"2025-03-28","current":-2.656626,"twenty":-7.395771,"median":-4.728869,"eighty":-3.400275,"marketCap":121054497},{"date":"2025-04-04","current":-1.603868,"twenty":-7.392983,"median":-4.702859,"eighty":-3.36039,"marketCap":73083433},{"date":"2025-04-11","current":-1.575606,"twenty":-7.289031,"median":-4.694849,"eighty":-3.31696,"marketCap":71795619},{"date":"2025-04-17","current":-1.42723,"twenty":-7.21366,"median":-4.648098,"eighty":-3.301626,"marketCap":65034596},{"date":"2025-04-21","current":-1.561475,"twenty":-7.19719,"median":-4.630925,"eighty":-3.287831,"marketCap":71151712}],"updateTime":1745314665136}}}